For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.
After finishing at $470.38 in the prior trading day, Unitedhealth Group Inc (NYSE: UNH) closed at $463.59, down -1.44%. In other words, the price has decreased by -$1.44 from its previous closing price. On the day, 5.1 million shares were traded.
Ratios:
Our goal is to gain a better understanding of UNH by taking a closer look at its different ratios. In the meantime, Its Debt-to-Equity ratio is 0.81 whereas as Long-Term Debt/Eq ratio is at 0.77.
On January 06, 2025, Truist reiterated its Buy rating and also upped its target price recommendation from $625 to $610.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jan 17 ’25 when FLYNN TIMOTHY PATRICK bought 1,000 shares for $511.57 per share. The transaction valued at 511,575 led to the insider holds 4,500 shares of the business.
McSweeney Erin sold 701 shares of UNH for $438,987 on Nov 11 ’24. The EVP & Chief People Officer now owns 7,105 shares after completing the transaction at $626.23 per share. On Nov 11 ’24, another insider, McSweeney Erin, who serves as the Officer of the company, bought 701 shares for $626.23 each.
Valuation Measures:
As of this moment, Unitedhealth’s Price-to-Earnings (P/E) ratio for their current fiscal year is 29.83, and their Forward P/E ratio for the next fiscal year is 13.84. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 2.65. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.07 while its Price-to-Book (P/B) ratio in mrq is 4.53.
Stock Price History:
Over the past 52 weeks, UNH has reached a high of $630.73, while it has fallen to a 52-week low of $436.38. The 50-Day Moving Average of the stock is -10.26%, while the 200-Day Moving Average is calculated to be -15.22%.
Shares Statistics:
A total of 920.28M shares are outstanding, with a floating share count of 918.30M. Insiders hold about 0.22% of the company’s shares, while institutions hold 89.09% stake in the company.
Earnings Estimates
The company has 22.0 analysts who recommend its stock at the moment. The consensus estimate for the next quarter is $7.5, with high estimates of $8.24 and low estimates of $7.22.
Analysts are recommending an EPS of between $30.22 and $29.38 for the fiscal current year, implying an average EPS of $29.77. EPS for the following year is $33.55, with 27.0 analysts recommending between $34.29 and $32.02.
Revenue Estimates
18 analysts predict $111.53B in revenue for the current quarter. It ranges from a high estimate of $113.91B to a low estimate of $109.26B. As of the current estimate, Unitedhealth Group Inc’s year-ago sales were $99.8BFor the next quarter, 18 analysts are estimating revenue of $112.36B. There is a high estimate of $113.54B for the next quarter, whereas the lowest estimate is $110.63B.
A total of 23 analysts have provided revenue estimates for UNH’s current fiscal year. The highest revenue estimate was $457.42B, while the lowest revenue estimate was $441.88B, resulting in an average revenue estimate of $452.03B. In the same quarter a year ago, actual revenue was $400.28BBased on 24 analysts’ estimates, the company’s revenue will be $485.52B in the next fiscal year. The high estimate is $498.6B and the low estimate is $462.74B.
